MarketGrader U.S. Income 100 Index


Five Largest Companies (Top 5 of 52)
Symbol Name Grade Market Cap Country
XOM Exxon Mobil Corporation 70.7 $360,762.00 US
PFE Pfizer Inc. 86.9 $294,179.00 US
CVX Chevron Corporation 62.7 $284,465.00 US
KO Coca-Cola Company 64.7 $272,717.00 US
ABBV AbbVie, Inc. 64.8 $270,651.00 US

Five Smallest Companies (Top 5 of 7)
Symbol Name Grade Market Cap Country
NEWT Newtek Business Services Corp. 46.6 $457.37 US
MSBI Midland States Bancorp, Inc. 63.7 $530.21 US
BIG Big Lots, Inc. 25.3 $606.40 US
ACCO ACCO Brands Corporation 56.0 $633.32 US
ACRE Ares Commercial Real Estate Corporation 58.7 $665.78 US

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
MMP Magellan Midstream Partners, L.P. 55.6 27 US
INTC Intel Corporation 67.0 20 US
UBSI United Bankshares, Inc. 58.8 20 US
VZ Verizon Communications Inc. 51.5 19 US
PFS Provident Financial Services, Inc. 70.3 19 US
FNB F.N.B. Corporation 61.1 19 US
NYCB New York Community Bancorp, Inc. 60.8 18 US
NWBI Northwest Bancshares, Inc. 56.3 17 US
PFE Pfizer Inc. 86.9 17 US
PNW Pinnacle West Capital Corporation 50.0 17 US
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap $40,140.06
Median Market Cap $9,305.09
Avg. 3 Mo. Dollar Vol. $236,261,388.14
Avg. 3 Mo. Trading Vol. 4,037,003
Last Rebalance Date 03/21/2022
Companies Replaced 37
Biggest Sector Increase Consumer Discretionary
Biggest Sector Decrease Consumer Staples

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 11.68
Forward P/E Ratio (12 Mo.) 10.42
Price/Book Ratio 2.11
Avg. Revenue Chg. - 3 Yr 14.83%
Avg. Op. Income Chg. - 3 Yr. 34.17%
Avg. EPS Growth - 3 Yr. 9.28%
Avg. EPS Growth - 1 Yr. 10.7%
Avg. Operating Margin 20.27%
Avg. LT Debt to Total Capital 54.78%
Avg. Return on Equity 22.58%
Dividend Yield 4.51%
Index Average Grade
MarketGrader U.S. Income 100 Index 59.0
Country Breakdown
United States Of America 91.0%
Canada 7.0%
Bermuda 1.0%


For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE